|
Volumn 4, Issue 2, 2000, Pages 73-82
|
Tissue-specific promoters in gene therapy for the treatment of prostate cancer
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ACICLOVIR;
ANDROGEN;
GANCICLOVIR;
LUCIFERASE;
OSTEOCALCIN;
PROSTATE SPECIFIC ANTIGEN;
THYMIDINE KINASE;
VALACICLOVIR;
VIRUS VECTOR;
ADENOVIRUS;
BONE METASTASIS;
CLINICAL TRIAL;
CONFERENCE PAPER;
DRUG CYTOTOXICITY;
GENE TARGETING;
GENE THERAPY;
GENETIC TRANSDUCTION;
HUMAN;
NONHUMAN;
OSTEOSARCOMA;
PRIORITY JOURNAL;
PROSTATE CANCER;
TISSUE SPECIFICITY;
|
EID: 0034046855
PISSN: 10915362
EISSN: None
Source Type: Journal
DOI: 10.1089/10915360050138620 Document Type: Conference Paper |
Times cited : (25)
|
References (20)
|